Human Genomics_Logo_Draft

First Page		Document Content
Immune system T cells Oncology Cancer treatments PD-1 Immunotherapy Cancer immunotherapy CD25 PD-L1 Medicine Immunology Biology		Human Genomics_Logo_Draft Add to Reading List Source URL: www.immunotherapyofcancer.org Download Document from Source Website File Size: 312,83 KB Share Document on Facebook

	# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,,#, Stephen M. Shaw 1,, Kim Wi DocID: 1vdls - View Document
	Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx DocID: 1uTyz - View Document
	FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program DocID: 1tGAn - View Document
	Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab DocID: 1tBVB - View Document